Publications

Quick Research

Filters Clear All

Any Time

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Country

Argentina
Australia
Austria
Bangladesh
Barbados
Belarus
Belgium
Brazil
Bulgaria
Burkina Faso
Cambodia
Cameroon
Canada
Chile
China
Chinese Taiwan
Croatia
Cyprus
Czech
Czechia
Denmark
Egypt
Estonia
Ethiopia
Finland
France
Gabon
Germany
Ghana
Greece
Guyana
Hungary
India
Iran
Ireland
Israel
Italy
Japan
Kenya
Korea
Kuwait
Luxembourg
Madagascar
Malaysia
Mexico
Mongolia
Morocco
Myanmar
Nepal
Netherlands
New Zealand
Niger
Nigeria
Norway
Pakistan
Philippines
Poland
Portugal
Romania
Russia
Russian Federation
Saudi Arabia
Singapore
Slovenia
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Thailand
Tunisia
Turkey
UAE
UK
USA
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vietnam

Procell has assisted our customers in publishing 25,274 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.

Filter

2023

Radiosensitizer-Based injectable hydrogel for enhanced radio-chemotherapy of TNBC (2024-06-26)

Journal: CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (2024) IF: 1.2

DOI: 10.1016/j.cjac.2024.100414

Products Cited: 4T1 Cells Line
Study on the anti-colon cancer effect of Renshen Yangrong Decoction based on network pharmacology, molecular docking, and in vivo and in vitro experiments (2024-11-12)

Journal: CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (2024) IF: 1.2

DOI: 10.1016/j.cjac.2024.100464

Products Cited: DMEM (High glucose) Medium, Penicillin-Streptomycin Solution, 100 ×, Fetal Bovine Serum
Terrestrosin D inhibits invasion and induces apoptosis through inhibition of STAT3 in anaplastic thyroid carcinoma (2024-06-03)

Journal: Molecular & Cellular Toxicology (2024) IF: 1.1

DOI: 10.1007/s13273-024-00457-3

Products Cited: Annexin V-FITC/PI Apoptosis Kit
STAT1 as a potential therapeutic target to treat bladder cancer (2024-09-15)

Journal: International Journal of Clinical and Experimental Pathology (2024) IF: 1.1

DOI: 10.62347/HYCN1717

Products Cited: T24 [T-24] Cells Line, SV-HUC-1 Cells Line, 5637 Cells Line
Activation of cGAS confers PARP inhibitor resistance in ovarian cancer via the TBK1-IRF3 axis (2024-11-15)

Journal: International Journal of Clinical and Experimental Pathology (2024) IF: 1.1

DOI: 10.62347/XOPN6908

Products Cited: SK-OV-3 Cells Line, OVCAR-8 Cells Line
XinJiaCongRongTuSiZiWan protects triptolide-induced rats from oxidative stress injury via mitophagy mediated PINK1/Parkin signaling pathway (2024-03-15)

Journal: Acta Cirurgica Brasileira (2024) IF: 1.1

DOI: 10.1590/acb391424

Products Cited: Human Ovarian Granulosa cells, Human Ovarian Granulosa cells Complete Medium
Pretreatment of artesunate promoted hepatocyte proliferation by activating the PI3K/Akt/mTOR signaling pathway in mice (2024-10-25)

Journal: Acta Cirurgica Brasileira (2024) IF: 1.1

DOI: 10.1590/acb394324

Products Cited: NCTC 1469 Cells Line
FOXM1 derived from Triple negative breast cancer exosomes promotes cancer progression by activating IDO1 transcription in macrophages to suppress ferroptosis and induce M2 polarization of Tumor-associated macrophages (2024-10-18)

Journal: GENES & GENETIC SYSTEMS (2024) IF: 1

DOI: 10.1266/ggs.24-00079

Products Cited: MCF7 [MCF-7] Cells Line, T-47D Cells Line, BT-474 [BT474] Cells Line, SK-BR-3 [SKBR3] Cells Line, MCF 10A Cells Line
Single-cell RNA sequencing and bulk sequencing reveal the immunosuppressive role of malignant cells in triple-negative breast cancer (2024-06-13)

Journal: Gene Reports (2024) IF: 1

DOI: 10.1016/j.genrep.2024.101952

Products Cited: DMEM/F12 Medium, Donor Equine Serum, 10 mg/mL Recombinant Human Insulin Solution, EGF/Urogastrone/URG, Human, Recombinant
miR-16-5p may modulate migration and proliferation through TP53 and LncRNA-NEAT1 in triple-negative breast cancer (2024-09-20)

Journal: Gene Reports (2024) IF: 1

DOI: 10.1016/j.genrep.2024.102038

Products Cited: MCF 10A Cell Complete Medium